The Cholesterol Synthesis Pathway as a Novel Therapeutic Target for Glioblastoma
The Cholesterol Synthesis Pathway as a Novel Therapeutic Target for Glioblastoma
批准号:
386661
负责人:
Yang De Hua
金额:
$1.27万
依托单位:
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2017
资助国家:
加拿大
项目状态:
已结题
起止时间:
2017-12-01 至 2018-12-01
中文摘要
胶质母细胞瘤是最常见和致命的脑癌。目前的护理标准包括非特效治疗,仅将患者的存活率提高了一小部分。确诊后患者平均存活时间为18个月。
英文摘要
Glioblastoma is the most common and lethal form of brain cancer. The current standard of care consists of non-specific treatments and only extend the survival rate of patients by a small fraction. The average patient survival following diagnosis is 18 mon
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金